Search results
Generic drug giants settle federal price-fixing charges
Politico via Yahoo News· 8 months agoTwo generic drug giants agreed Monday to settle long-running criminal price-fixing charges with the...
How one U.S. drugmaker contributed to the escalating drug shortage crisis
NBC News via Yahoo News· 9 months agoWhen Akorn Pharmaceuticals shut its doors in February, hospitals across the country felt it. The...
DOJ settles price-fixing charges against generic drug giants
The Hill via Yahoo News· 8 months agoTwo major generic drug companies Monday settled charges of criminal price fixing with the Department...
Pharma's expensive gaming of the drug patent system is successfully countered by the Medicines...
The Conversation via Yahoo News· 1 year agoDrug patents don't necessarily spur companies to innovate so much as restrict access to their IP....
3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
Zacks via Yahoo Finance· 2 weeks agoThe impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually...
Here's Why You Should Add Dr. Reddy's (RDY) to Your Portfolio
Zacks via Yahoo Finance· 8 months agoDr. Reddy's (RDY) continues to enjoy a strong foothold in the global generics market due to its deep...
30 Wealthiest People in India
Insider Monkey via Yahoo Finance· 7 hours agoIn this article, we will look into the 30 wealthiest people in India. If you want to skip our detailed analysis of the Indian economy, you can go...
WHO approves generic Paxlovid drug for covid treatment in low-income countries
Quartz via Yahoo Finance· 1 year agoThe generic version of Paxlovid, the Pfizer-made antiviral drug that is the best treatment choice...
Contaminated Drugs, Shredded Papers: US FDA Uncovers Failures in India Pharma Factories
Bloomberg via Yahoo News· 11 months ago(Bloomberg) -- US inspectors have in recent months uncovered wide-ranging lapses at factories run by...
U.S. Supreme Court rebuffs Novartis, allows generic versions of MS drug
Reuters via Yahoo News· 2 years agoThe U.S. Supreme Court on Thursday turned down Novartis' bid to block the launch of generic versions...